Loading data for BCYC — first visit, this takes a few seconds.
Bicycle Therapeutics (BCYC)
NasdaqGS: BCYC
· リアルタイム株価 · USD
4.12
+0.13 (3.26%)
終値時点: Aug 14, 2026, 8:00 PM
3.95
+1.28%
時間外: 7:34 PM
Bicycle Therapeutics (BCYC) Stock Price, Analysis & Data
3.26% (1D)
データがありません
BCYCについて
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clin...
企業情報の全文決算サプライズ
Bicycle TherapeuticsはJul 30, 2026に四半期決算を発表しました:
2ページ中1ページ
